Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis

TY - JOUR

T1 - Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis

AU - Stephen Klinger, Daniel J. Pearce,

AU - Ziel, Kristin

AU - Steven R. Feldman, Emma J. Murad, Richard Rowell,

AU - Haushalter, Kristin

N1 - OBJECTIVE: In practice, lower dose acitretin therapy (25 mg/d) seems to be better tolerated and associated with fewer abnormalities found after laboratory testing. Here we revisit the original phase 3 trials for acitretin to evaluate the evidence for low-dose therapy producing fewer adverse effects than the 50 mg/d dosage.

PY - 2006

Y1 - 2006

UR - https://www.ncbi.nlm.nih.gov/pubmed/16924049

M3 - Article

VL - 142

JO - Archives of dermatology

JF - Archives of dermatology

ER -